ERIBULIN for Breast cancer metastatic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,152 adverse event reports in the FDA FAERS database where ERIBULIN was used for Breast cancer metastatic.
Most Reported Side Effects for ERIBULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 675 | 13.4% | 112 | 289 |
| Malignant neoplasm progression | 594 | 11.8% | 228 | 158 |
| Myelosuppression | 520 | 10.3% | 2 | 380 |
| Febrile neutropenia | 448 | 8.9% | 65 | 378 |
| Neutrophil count decreased | 294 | 5.8% | 14 | 159 |
| Neuropathy peripheral | 290 | 5.7% | 44 | 124 |
| White blood cell count decreased | 289 | 5.7% | 10 | 146 |
| Pyrexia | 275 | 5.4% | 66 | 218 |
| Disease progression | 211 | 4.2% | 67 | 53 |
| Fatigue | 209 | 4.1% | 72 | 111 |
| Anaemia | 188 | 3.7% | 29 | 108 |
| Leukopenia | 185 | 3.7% | 51 | 103 |
| Nausea | 183 | 3.6% | 48 | 102 |
| Interstitial lung disease | 171 | 3.4% | 30 | 91 |
| Thrombocytopenia | 168 | 3.3% | 55 | 87 |
Other Indications for ERIBULIN
Breast cancer (1,736)
Product used for unknown indication (355)
Breast cancer recurrent (346)
Triple negative breast cancer (171)
Invasive ductal breast carcinoma (127)
Her2 positive breast cancer (108)
Soft tissue sarcoma (66)
Breast cancer stage iv (58)
Chemotherapy (52)
Her-2 positive breast cancer (50)
Other Drugs Used for Breast cancer metastatic
PALBOCICLIB (18,160)
RIBOCICLIB (9,771)
LETROZOLE (6,856)
TRASTUZUMAB (6,303)
FULVESTRANT (4,570)
PERTUZUMAB (3,784)
CAPECITABINE (3,691)
PACLITAXEL (3,241)
DOCETAXEL (3,070)
EVEROLIMUS (2,751)